
Roham Zamanian
@docroham
Professor of Medicine ; Director Adult Pulmonary Hypertension Program ; Associate Director Vera Moulton Wall Center; clinical trialist ; photographer.
ID: 844963244
http://wallcenter.stanford.edu 25-09-2012 06:02:46
653 Tweet
1,1K Takipçi
634 Takip Edilen

Drug Induced Pulmonary Hypertension Symposium at Stanford is 1 week away! HYBRID (In person & Live Streaming). Not too late to join us. Registration is still open. Stanford Wall Center Stanford PACCM Stanford Department of Medicine


Kicking off the Stanford University Drug Induced #PulmonaryHypertension symposium Fantastic lineup ahead. Thanks to Roham Zamanian for the invitation #DIPH Stanford Wall Center


Happy to discuss genetics in drugs-associated PAH at Stanford University University. Thanks to Roham Zamanian for the invitation #DIPH Stanford Wall Center Pulmotension FSMR - RespiFIL 🫁 InsermU999




Olivier Sitbon discusses the approach to Dasatinib-associated PAH at the Stanford University Drug Induced PH symposium 1️⃣Stop the drug! 2/3 will resolve with discontinuation alone 2️⃣Treatment based on risk/severity. Roham Zamanian Vinicio de Jesus Perez, MD FAHA FCCP ATSF @pvri



DIPH Symposium PVOD induced by alkylating agents & solvents by Prof Humbert Inserm Stanford Wall Center Stanford PACCM



Congratulations to Andy Sweatt & Adam Andruska for amazing presentations on vasoreactivity in PAH & PVOD risk score. Did us proud!! ATS PC Assembly American Thoracic Society (ATS) Stanford PACCM


Dr Andrew Sweatt - The Jane Moris Award recipient ATS PC Assembly Congratulations Andy!!!!!! Made us proud. Stanford PACCM Stanford Wall Center



RIP Major Brian Shul! Incredible story of an aviator. - resilience, courage, and grit. Spoke at our Stanford Wall Center pulmonary hypertension symposium a few years ago…. nytimes.com/2023/05/30/us/…

Difficult news to hear….a huge loss for the field and our community. On behalf of Stanford Wall Center, our deepest condolences to the Newman family and Vanderbilt colleagues. His legacy will live on thru his contributions to our field and the many he has mentored.


A pleasure to help pave to define disease modification in PAH. An honor to work with a superb group of colleagues - Exciting think-tank style collab, along with the ever-so-important patient perspective pubmed.ncbi.nlm.nih.gov/38471030/ Stanford Wall Center Jason Weatherald MD The Pulmonary Vascular Research Institute

Incredible. Hats off to all scientists/investigators/patients(!). Excited to have access to therapy w such a potential. BUT!!!! Inaccurate& misleading news will NOT help our field or patients. Opinion is not fact! The Pulmonary Vascular Research Institute Vinicio de Jesus Perez, MD FAHA FCCP ATSF Jason Weatherald MD cnn.com/2024/03/26/hea…
